Clinical Evaluation of Computer-Aided Colorectal Neoplasia Detection Using a Novel Endoscopic Artificial Intelligence: A Single-Center Randomized Controlled Trial
Digestion · 2023 · 104 (3) · 193-201
DOI: 10.1159/000528085 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Digestion, online erschienen am 04.01.2023. Verfasst von Hirotaka Nakashima und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Foundation for Detection of Early Gastric Carcinoma, Tokyo, Japan. Hauptthemen laut MEDLINE: Colonic Polyps, Colonic Neoplasms, Adenoma, Colorectal Neoplasms. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Introduction
Computer-aided diagnostic systems are emerging in the field of gastrointestinal endoscopy. In this study, we assessed the clinical performance of the computer-aided detection (CADe) of colonic adenomas using a new endoscopic artificial intelligence system.
Methods
This was a single-center prospective randomized study including 415 participants allocated into the CADe group (n = 207) and control group (n = 208). All endoscopic examinations were performed by experienced endoscopists. The performance of the CADe was assessed based on the adenoma detection rate (ADR). Additionally, we compared the adenoma miss rate for the rectosigmoid colon (AMRrs) between the groups.
Results
The basic demographic and procedural characteristics of the CADe and control groups were as follows: mean age, 54.9 and 55.9 years; male sex, 73.9% and 69.7% of participants; and mean withdrawal time, 411.8 and 399.0 s, respectively. The ADR was 59.4% in the CADe group and 47.6% in the control group (p = 0.018). The AMRrs was 11.9% in the CADe group and 26.0% in the control group (p = 0.037).
Conclusion
The colonoscopy with the CADe system yielded an 11.8% higher ADR than that performed by experienced endoscopists alone. Moreover, there was no need to extend the examination time or request the assistance of additional medical staff to achieve this improved effectiveness. We believe that the novel CADe system can lead to considerable advances in colorectal cancer diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Foundation for Detection of Early Gastric Carcinoma, Tokyo, Japan.
- Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
- Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
- Medical Simulation Center, Jichi Medical University, Tochigi, Japan.
Zitieren
APA
Nakashima, H., Kitazawa, N., Fukuyama, C., Kawachi, H., Kawahira, H., Momma, K., & Sakaki, N. (2023). Clinical Evaluation of Computer-Aided Colorectal Neoplasia Detection Using a Novel Endoscopic Artificial Intelligence: A Single-Center Randomized Controlled Trial. Digestion, 104(3), 193-201. https://doi.org/10.1159/000528085
Vancouver
Nakashima H, Kitazawa N, Fukuyama C, Kawachi H, Kawahira H, Momma K, et al. Clinical Evaluation of Computer-Aided Colorectal Neoplasia Detection Using a Novel Endoscopic Artificial Intelligence: A Single-Center Randomized Controlled Trial. Digestion. 2023;104(3):193-201. doi:10.1159/000528085
BibTeX
@article{Nakashima2023,
author = {Nakashima, Hirotaka and Kitazawa, Naoko and Fukuyama, Chika and Kawachi, Hiroshi and Kawahira, Hiroshi and Momma, Kumiko and Sakaki, Nobuhiro},
title = {Clinical Evaluation of Computer-Aided Colorectal Neoplasia Detection Using a Novel Endoscopic Artificial Intelligence: A Single-Center Randomized Controlled Trial},
journal = {Digestion},
year = {2023},
volume = {104},
number = {3},
pages = {193--201},
doi = {10.1159/000528085}
}
EUVIMED